Incretin-Based Therapies and Diabetic Retinopathy: Real-World Evidence in Older U.S. Adults

摘要

OBJECTIVERecent large trials yield conflicting results on the association between incretin-based therapies (IBTs) and diabetic retinopathy (DR). We examined whether IBTs increase DR risk compared with other antihyperglycemics.